Argatroban Stroke Treatment - A Pilot Safety Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew D. Barreto, MD
The University of Texas Health Science Center, Houston
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama-Birmingham
Birmingham, Alabama, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Tulane University
New Orleans, Louisiana, United States
- University of Texas-Southwestern Dallas
Dallas, Texas, United States
- Memorial Hermann Hospital-Medical Center
Houston, Texas, United States
- Memorial Hermann Southwest Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2003
- Primary completion
- 31 Aug 2010
- Completion
- 31 Aug 2010
- Last update posted
- 10 Nov 2014
- Registered enrollment
- 65
- Registry id
- NCT00268762
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.